Canada · Health Canada Drug Product Database

BUPROPION HYDROCHLORIDE

Source ingredient · 37 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

Canada · Source reference 84839

AVA-BUPROPION SR

Tablet (Extended-Release) / AVANSTRA INC

Canada · Source reference 84840

AVA-BUPROPION SR

Tablet (Extended-Release) / AVANSTRA INC

Canada · Source reference 87131

BUPROPION HCL SR

Tablet (Extended-Release) / BAUSCH HEALTH, CANADA INC.

Canada · Source reference 86895

BUPROPION HCL XL

Tablet (Extended-Release) / BAUSCH HEALTH, CANADA INC.

Canada · Source reference 86896

BUPROPION HCL XL

Tablet (Extended-Release) / BAUSCH HEALTH, CANADA INC.

Canada · Source reference 106413

BUPROPION HYDROCHLORIDE XL

Tablet (Extended-Release) / YICHANG HUMANWELL PHARMACEUTICAL CO., LTD.

Canada · Source reference 106414

BUPROPION HYDROCHLORIDE XL

Tablet (Extended-Release) / YICHANG HUMANWELL PHARMACEUTICAL CO., LTD.

Canada · Source reference 81075

BUPROPION SR

Tablet (Extended-Release) / PRO DOC LIMITEE

Canada · Source reference 81729

BUPROPION SR

Tablet (Extended-Release) / PRO DOC LIMITEE

Canada · Source reference 87689

BUPROPION SR

Tablet (Extended-Release) / SANIS HEALTH INC

Canada · Source reference 87690

BUPROPION SR

Tablet (Extended-Release) / SANIS HEALTH INC

Canada · Source reference 96230

CONTRAVE

Tablet (Extended-Release) / BAUSCH HEALTH, CANADA INC.

Canada · Source reference 80330

DOM-BUPROPION SR

Tablet (Extended-Release) / DOMINION PHARMACAL

Canada · Source reference 81752

DOM-BUPROPION SR

Tablet (Extended-Release) / DOMINION PHARMACAL

Canada · Source reference 86794

MYLAN-BUPROPION XL

Tablet (Extended-Release) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 86795

MYLAN-BUPROPION XL

Tablet (Extended-Release) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 78486

NOVO-BUPROPION SR

Tablet (Extended-Release) / NOVOPHARM LIMITED

Canada · Source reference 74546

NOVO-BUPROPION SR TABLETS

Tablet (Extended-Release) / NOVOPHARM LIMITED

Canada · Source reference 76058

ODAN BUPROPION SR

Tablet (Extended-Release) / ODAN LABORATORIESLTD

Canada · Source reference 76059

ODAN BUPROPION SR

Tablet (Extended-Release) / ODAN LABORATORIESLTD

Canada · Source reference 106839

ODAN-BUPROPION XL

Tablet (Extended-Release) / ODAN LABORATORIESLTD

Canada · Source reference 106840

ODAN-BUPROPION XL

Tablet (Extended-Release) / ODAN LABORATORIESLTD

Canada · Source reference 80331

PHL-BUPROPION SR

Tablet (Extended-Release) / PHARMEL INC

Canada · Source reference 81751

PHL-BUPROPION SR

Tablet (Extended-Release) / PHARMEL INC

Canada · Source reference 79896

PMS-BUPROPION SR

Tablet (Extended-Release) / PHARMASCIENCE INC

Canada · Source reference 81077

PMS-BUPROPION SR

Tablet (Extended-Release) / PHARMASCIENCE INC

Canada · Source reference 77116

RATIO-BUPROPION SR

Tablet (Extended-Release) / TEVA CANADA LIMITED

Canada · Source reference 77117

RATIO-BUPROPION SR

Tablet (Extended-Release) / TEVA CANADA LIMITED

Canada · Source reference 96647

TARO-BUPROPION XL

Tablet (Extended-Release) / SUN PHARMA CANADA INC

Canada · Source reference 96648

TARO-BUPROPION XL

Tablet (Extended-Release) / SUN PHARMA CANADA INC

Browse ingredients in Canada →